Valuation: Inspire Medical Systems, Inc.

Capitalization 3.83B 3.32B 3.13B 2.85B 5.25B 331B 5.93B 36.91B 14.16B 152B 14.35B 14.05B 559B P/E ratio 2025 *
57.9x
P/E ratio 2026 * 41.2x
Enterprise value 3.4B 2.95B 2.78B 2.53B 4.67B 294B 5.27B 32.81B 12.58B 135B 12.76B 12.48B 497B EV / Sales 2025 *
3.58x
EV / Sales 2026 * 2.84x
Free-Float
99.03%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.93%
1 week+1.79%
Current month-5.27%
1 month-12.60%
3 months-19.51%
6 months-29.40%
Current year-29.38%
More quotes
1 week 126.01
Extreme 126.01
133.33
1 month 125.22
Extreme 125.22
149.71
Current year 125.22
Extreme 125.22
216.01
1 year 123
Extreme 123
225
3 years 123
Extreme 123
330
5 years 82.77
Extreme 82.77
330
10 years 22.5
Extreme 22.5
330
More quotes
Manager TitleAgeSince
Chief Executive Officer 62 2007-10-31
Director of Finance/CFO 57 2014-05-15
Compliance Officer 53 2021-01-18
Director TitleAgeSince
Chairman 62 2024-05-01
Director/Board Member 65 2008-06-30
Director/Board Member 67 2007-12-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.93%+1.79%-19.38%-21.32% 3.83B
+0.62%-1.30%+7.71%+93.50% 143B
+0.51%-2.70%+8.95%-5.51% 12.62B
+1.04%-5.73%-7.25%-56.75% 7.12B
-2.14%+2.61%-11.68%+130.28% 5.84B
+0.75%-.--%+5.14%+47.08% 3.63B
+0.31%-5.78%+30.75%-4.92% 2B
+1.03%-4.42%-0.03%-17.51% 1.92B
-1.79%-6.75%-32.50%-46.69% 1.75B
-0.55%-5.93%-21.34%-38.61% 1.45B
Average +0.07%-2.43%-3.96%+7.96% 18.28B
Weighted average by Cap. +0.52%-2.01%+5.53%+74.03%
See all sector performances

Financials

2025 *2026 *
Net sales 949M 824M 776M 706M 1.3B 82.16B 1.47B 9.16B 3.51B 37.63B 3.56B 3.49B 139B 1.11B 966M 910M 828M 1.53B 96.34B 1.73B 10.74B 4.12B 44.13B 4.18B 4.09B 163B
Net income 69.02M 59.92M 56.43M 51.33M 94.78M 5.97B 107M 666M 255M 2.74B 259M 253M 10.08B 98.09M 85.16M 80.21M 72.95M 135M 8.49B 152M 947M 363M 3.89B 368M 360M 14.33B
Net Debt -426M -369M -348M -317M -584M -36.84B -660M -4.11B -1.57B -16.87B -1.6B -1.56B -62.16B -663M -576M -542M -493M -911M -57.42B -1.03B -6.4B -2.45B -26.3B -2.49B -2.44B -96.88B
More financial data * Estimated data
Logo Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. It has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
Employees
1,246
More about the company
Date Price Change Volume
25-06-20 130.91 $ +0.93% 565,897
25-06-18 129.70 $ +1.93% 590,834
25-06-17 127.25 $ -1.90% 718,091
25-06-16 129.71 $ +1.99% 536,416
25-06-13 127.18 $ -1.11% 983,743

Delayed Quote Nyse, June 20, 2025 at 04:00 pm EDT

More quotes
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
129.70USD
Average target price
213.58USD
Spread / Average Target
+64.67%
Consensus

Quarterly revenue - Rate of surprise